Willi Leimer

Gapfruit is a modern capability-based microkernel operating system. Gapfruit is hardware agnostic and scales from specialized embedded systems, over carrier-grade appliances to high performance cloud servers. The OS architecture gives complete control over all software stacks and allows to form rational arguments as to why the platform is considered trustworthy.

NEXILIS is a Swiss MedTech company with a progressive technology that improves implant stabilization in patients with poor bone quality. This is achieved by better and more reliable anchorage of fixation screws in bone. Using the NEXILIS immediate stabilization system (ISS) results in a significantly improved interface between screws and surrounding bone. This is the base for a safe healing process and durable treatment effect.

Minolite is developing light-weight aggregates that enhance the performance of building materials and enable the construction of sustainable cities and communities. Our carbon free production process upcycles recycled glass into high value circular products that outperform all existing light weight aggregates (LWA) in the market today. It reduces the carbon footprint, improves the recycling ratio of low quality glass fines, and supports the circular economy.

Helvetica Capital AG was founded in 2015 as an independent investment firm which arose from the team behind SVC Ltd. for Risk Capital for SMEs, a wholly owned subsidiary of Credit Suisse. Since 2010, our team at SVC Ltd. (in 2018 renamed Credit Suisse Entrepreneur Capital Ltd. or CSEC) has built up an attrac-tive portfolio with direct investments in Swiss SMEs in the venture, growth and later stage areas, which Helvetica Capital continues to manage and further develop as exclusive advisor to CSEC. In addition, in 2019 Helvetica Capital AG was mandated by Credit Suisse as investment advisor to the Swiss Entrepre-neur Fund (SwissEF) with responsibility for the direct investment activities of the fund. Finally, over the past four years Helvetica Capital AG has built up the Entrepreneur-Investor-Platform (EIP) and has already successfully completed six transactions resulting in majority / controlling interest in these companies. The Entrepreneur-Investor-Platform connects the most successful entrepreneurs and investors of Switzerland with attractive SMEs and thus ensures an active, long-term and independent development of these com-panies. Helvetica Capital AG should not be considered a traditional private capital player, but acts as a long-term partner to companies, bringing with it the expertise and network of its entrepreneurial families. The latter, together with Helvetica Capital, directly participate as co-investors and are not dependent on a quick exit. www.helvetica-capital.ch

Sika is a specialty chemicals company with a globally leading position in the development and production of systems and products for bonding, sealing, damping, reinforcing, and protection in the building sector and industrial manufacturing. Sika has subsidiaries in 102 countries around the world and, in over 400 factories, produces innovative technologies for customers worldwide. In doing so, it plays a crucial role in enabling the transformation of the construction and transportation sector toward greater environmental compatibility. With more than 34,000 employees, the company generated sales of CHF 11.76 billion in 2024. On Sikas LinkedIn page we share our most important corporate news and job openings, as well as a broad mix of content from our Sika subsidiaries around the world. Your Career at Sika: https://www.sika.com/en/career.html

Gapfruit is a modern capability-based microkernel operating system. Gapfruit is hardware agnostic and scales from specialized embedded systems, over carrier-grade appliances to high performance cloud servers. The OS architecture gives complete control over all software stacks and allows to form rational arguments as to why the platform is considered trustworthy.

NEXILIS is a Swiss MedTech company with a progressive technology that improves implant stabilization in patients with poor bone quality. This is achieved by better and more reliable anchorage of fixation screws in bone. Using the NEXILIS immediate stabilization system (ISS) results in a significantly improved interface between screws and surrounding bone. This is the base for a safe healing process and durable treatment effect.

Minolite is developing light-weight aggregates that enhance the performance of building materials and enable the construction of sustainable cities and communities. Our carbon free production process upcycles recycled glass into high value circular products that outperform all existing light weight aggregates (LWA) in the market today. It reduces the carbon footprint, improves the recycling ratio of low quality glass fines, and supports the circular economy.

Headquartered in Zurich, Switzerland, Turos Capital is a specialised finance boutique that supports European healthcare companies with venture capital and advisory services from seed capital until exit. A strong management team with a compelling investment case must be supported by the best available investors, who also share its vision for the company and are willing to commit longterm. Turos Capitals wide network across different types of investors allows a selective approach to match the most suitable investors with each specific investment opportunity. We bring extensive experience and professionalism to every investment case and customise our service and advice to our clients’ needs and concerns. We work with our clients to help them recognise and address the challenges and risks associated with their investment case. Our team on the ground is supported by a dedicated panel of senior advisors and by a global network of industry experts.